Invesco has launched the China Healthcare Equity Fund, a Ucits-compliant Sicav aimed at capturing the opportunities in the country's expanding healthcare sector fuelled by "robust growth" in spending. Hong Kong-based senior fund manager Chris Liu will invest primarily in Chinese healthcare companies mainly listed on the Shanghai or Shenzhen Stock Exchanges and traded via Stock Connect, holding between 30 and 40 stocks in the portfolio. Invesco said the fund's growth-orientated strategy will see the manager focus on healthcare mid-cap stocks, investing in Chinese companies with "sustai...
To continue reading this article...
Join International Investment
Signup and gain exclusive members-only insights
Join International Investment today
Unlock members-only benefits:
- Unlimited access to real-time news, industry insights, video features and market intelligence
- Stay ahead of the curve with spotlights on international financial centres, regional trends international advice and global industry leaders
- Receive breaking news stories straight to your inbox in the daily newsletters
- Hear the latest cross jurisdictional developments in wealth planning, tax, regulation, investing, retirement and protection
- Members-only access to the Editor’s weekly news roundup newsletter
- Members-only access to analysis via our exclusive industry polls
- Be the first to hear about our events and awards programmes
